Colestilan decreases weight gain by enhanced NEFA incorporation in biliary lipids and fecal lipid excretion

Effects of bile-acid-binding resin (colestimide) on blood glucose and visceral fat in Japanese patients with type 2 diabetes mellitus and hypercholesterolemia: an open-label, randomized, case–control, crossover study

(2012) Tatsuya Suzuki et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Bile acid sequestrants

(2011) Carolien Out et al.   CURRENT OPINION IN LIPIDOLOGY

Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia

(2011) Tadashi Yamakawa et al.   ENDOCRINE JOURNAL

Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure

(2011) Mitsuhiro Watanabe et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1

(2010) Quan Shang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Plasma bile acids are not associated with energy metabolism in humans

(2010) Gemma Brufau et al.   Nutrition & Metabolism

Time-Resolved and Tissue-Specific Systems Analysis of the Pathogenesis of Insulin Resistance

(2010) Robert Kleemann et al.   PLoS One

Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: Studies using genetically engineered mouse models

(2009) Peter J. Voshol et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Colestilan monotherapy significantly improves glycaemic control and LDL cholesterol levels in patients with type 2 diabetes: a randomized double-blind placebo-controlled study

(2009) K. Kondo et al.   DIABETES OBESITY & METABOLISM

Efficacy and Safety of Colesevelam in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Receiving Insulin-Based Therapy

(2008) Ronald B. Goldberg   ARCHIVES OF INTERNAL MEDICINE

Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes Mellitus Treated With Metformin

(2008) Harold E. Bays et al.   ARCHIVES OF INTERNAL MEDICINE

Modulating LDL cholesterol and glucose in patients with type 2 diabetes mellitus: targeting the bile acid pathway

(2008) Allison B Goldfine   CURRENT OPINION IN CARDIOLOGY

Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy

(2008) V. A. Fonseca et al.   DIABETES CARE